恶性胸腔积液的综合治疗新进展

王立伟, 焦顺昌

王立伟, 焦顺昌. 恶性胸腔积液的综合治疗新进展[J]. 中国肿瘤临床, 2006, 33(4): 236-239.
引用本文: 王立伟, 焦顺昌. 恶性胸腔积液的综合治疗新进展[J]. 中国肿瘤临床, 2006, 33(4): 236-239.
Wang Li-wei, Jiao Shun-chang. The Recent Advancement in Comprehensive Treatment of Malignant Pleural Effusions[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(4): 236-239.
Citation: Wang Li-wei, Jiao Shun-chang. The Recent Advancement in Comprehensive Treatment of Malignant Pleural Effusions[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(4): 236-239.

恶性胸腔积液的综合治疗新进展

详细信息
    通讯作者:

    王立伟 wlw168@126.com

  • 中图分类号: R730.5

The Recent Advancement in Comprehensive Treatment of Malignant Pleural Effusions

  • 摘要: 恶性胸腔积液(malignantpleuraleffusion,MPE)是晚期恶性肿瘤的常见并发症。MPE治疗的主要目的在于有效地控制胸腔积液,缓解呼吸困难,提高生活质量,延长生存期。本文综述了近年来MPE的多学科多模式的综合治疗现状及研究进展,特别是生物治疗等近年来的研究热点,总结了近年来出现的新药物及新手段。
    Abstract: The malignant pleural effusions(MPE)is a common complication in advanced malignancies.The main purpose of MPE therapy lies in effective control of pleural effusions,ease of dyspnea,enhancement of the quality of life and extension of survival time.The article sums up recent comprehensive treatment status and research development of the multidisciplinary modes of MPE,esp.the hot spot such as biotherapy,etc.and summarizes the new drugs and novel means occurred in recent years.
  • [1] 1 Am J. Management of Malignant Pleural Effusions [J]. Respir Crit Care Med, 2000, 162(5):1987-2001
    2 吴一龙. 肺癌多学科综合治疗的理论与实践[M].北京:人民卫生出版社,2000.277
    3 Sahn SA. Management of malignant pleural effusions [J]. Monaldi Arch Chest Dis, 2001, 56(5):394- 399
    4 Sahin U, Unlu M. The Value of small- bore catheter thoracostomy in the treatment of malignant pleural effusions[J]. Respiration, 2001, 68(5):501-505
    5 毛娟华. 顺铂联合白细胞介素-2 治疗恶性胸水[J].中国肿瘤,2004,13(4):257-258
    6 张洪娜.胸腔内注射TNF治疗恶性胸腔积液疗效分析[J].中华临床新医学,2004,4(10):907-908
    7 林菁, 张军一, 李鸣芳,等.自体TIL治疗恶性胸腔积液的临床疗效观察[J].临床军医杂志,2004,32(6):73-75
    8 周陈西, 章杰.短小棒状杆菌菌苗治疗恶性胸腔积液的临床观察[J]. 肿瘤学杂志,2003,9(4):225-226
    9 王昌明, 曾锦荣, 莫碧文.胞必佳联合顺铂治疗恶性胸水的疗效观察[J]. 华夏医学,2002,15(3):281-282
    10 官成浓,银正民,马桂贤,等.高聚金葡素治疗癌性胸腔积液的临床 研究[J].肿瘤防治研究,2004,31(4):241-242
    11 Katano M, Morisaki T. The past, the present and future of the OK- 432 therapy for patients with malignant effusions [J]. Anticancer Res, 1998, 18(5D):3917-3925
    12 蒋沈君, 刘云霞.中药针剂胸腔内注射治疗恶性胸腔积液述要[J]. 实用中医内科杂志, 2004,18(6):489-490
    13 Cardillo G, Facciolo F, Carbone L, et al. Long- term follow- up of video - assisted talc pleurodesis in malignant recurrent pleural effusions [J]. Eur J Cardiothorac Surg, 2002, 21(2):302-305
    14 Brant A, Eaton T. Serious complications with talc slurry pleurodesis[J]. Respirology, 2001, 6(3):181-185
    15 Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery:thoracoscopic talc pleurodesis and pleu - roperitoneal shunts in 101 patients[J]. Ann ThoracSurg, 2001, 71(6):1809-1812
    16 Genc O, Petrou M, Ladas G, et al. The long- term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions [J]. Eur J Cardiothorac Surg, 2000, 18(2):143-146
    17 Antunes G, Neville E, J Duffy J, et al. BTS guidelines for the management of malignant pleural effusions [J]. Thorax, 2003, 58(Suppl 2):29-38
    18 黄日茂, 陈胜喜, 罗万俊,等.胸腔镜在大量胸腔积液外科诊治中的应用[J]. 中国内镜杂志,2003,9(8):60
    19 Suzuki K, Funai K, Shundo Y, et al. Extrapleural pneumonectomy after hyperthermo- chemotherapy for the lung cancer patients with malignant pleural effusion [J]. Kyobu Geka, 2004, 57(11):1023-1027
    20 郭祖峰, 张帮慧, 程静. 射频透热联合化疗治疗恶性胸腔积液的临床评价[J]. 中国临床药理学与治疗学,2004,9(9):1065- 1068
计量
  • 文章访问数:  14
  • HTML全文浏览量:  1
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2005-10-20
  • 修回日期:  2006-01-08
  • 发布日期:  2006-02-27

目录

    /

    返回文章
    返回